First Cited
Last Cited

Articles citing This Document (Page 1 of 1)

Evolution of a Paradigm Switch in Diagnosis and Treatment of HPV-Driven Head and Neck Cancer-Striking the Balance Between Toxicity and Cure.Frontiers in Pharmacology2021
Machine Learning-Guided Adjuvant Treatment of Head and Neck CancerJAMA Network Open2020
Deintensification Strategies Using Proton Beam Therapy for HPV-Related Oropharyngeal CancerInternational Journal of Particle Therapy2021
Oropharyngeal Carcinoma Treated with Surgery Alone: Outcomes and Predictors of FailureAnnals of Otology, Rhinology and Laryngology2021
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trialBMC Cancer2020
Present and Future of De-intensification Strategies in the Treatment of Oropharyngeal CarcinomaCurrent Oncology Reports2020
A systematic review on Transoral robotic surgery (TORS) for carcinoma of unknown primary origin: Has tongue base mucosectomy become indispensable?Clinical Otolaryngology2020
Late and Long-Term Treatment-Related Effects and Survivorship for Head and Neck Cancer PatientsCurrent Treatment Options in Oncology2020
Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approachBritish Journal of Cancer2019
Patterns of care and survival impact of adjuvant chemoradiotherapy for oropharyngeal cancer with intermediate-risk featuresHead and Neck2019
Oropharyngeal Cancers in the East and the West - Implications of Aetiopathogenesis on Prognosis and ResearchClinical Oncology2019
Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient ageOral Oncology2018
Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS)Oral Oncology2018
De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinomaThe Cochrane Library2018
Radiation Therapy for Oral Cavity and Oropharyngeal CancersDental Clinics of North America2018
Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validationCancer2017
Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivorsHead and Neck2017
Assessment of adjuvant therapy in resected head and neck cancer with high-risk featuresOral Oncology2017
Intensity-modulated radiotherapy in head and neck cancer - an update for oral and maxillofacial surgeonsBritish Journal of Oral and Maxillofacial Surgery2017
The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinomaCancer2017
Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancerHead and Neck2017
Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data BaseCancer2016
Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control studyCancers of the Head & Neck2016
De-intensification of adjuvant therapy in human papillomavirus-associated oropharyngeal cancerCancers of the Head & Neck2016
Transoral robotic surgery: The radiation oncologist's perspectiveOral Oncology2016
Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell CarcinomasScientific Reports2016
Primary Surgical Management of Oropharyngeal Squamous Cell CarcinomaCurrent Otorhinolaryngology Reports2015